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Introduccion: Cytokeratins (CK) are molecules of the cytoskeleton that contribute to the cellular differenciation. We 
studied the expression of CK1, CK13 and CK14 in thirty-three patients with OLP. The biopsied lesions were located 
in the dorsal surface of the tongue, the palatal keratinized mucosa and the nonkeratinized buccal mucosa. 
Objectives: This study aimed to determine the expression of CK1, CK13 and CK14 in oral lichen planus (OLP) and 
its relations with: clinical patterns, prognosis, drugs and tobacco intake and histopathological features.
Study Design: Immunohistochemical analysis, retrospective, descriptive, observational and no randomized study.
Results: No significant difference was observed in the expression of CK1 in patients with or without drug treat-
ment. No association was found with the amount of drugs intake or smoking nor with the histopathological fea-
tures examined. Samples immunostained with CK13 were all positive in the suprabasal layers, and 13 of them in 
the basal layer. In these last ones, statistical analysis showed significance in the grade of vacuolization of the basal 
layer (p=0.023) and in the degree of exocytosis (p=0.0025), this, making the degree of affection higher for both 
parameters. Thirty-two tissue sections were immunostained with CK14. CK14 was expressed in the basal layer in 
97% of samples and in the suprabasal layer in 94% of samples.
Conclusions: The three CK were altered in OLP. CK1 does not have a direct connection with the presence of or-
thokeratosis. The finding of the CK13 in the basal layer is related to the agression of the lymphocytic infiltration 
in the epithelium, due to the basal stratum vacuolization and the increase in lymphocytic exocitosis. The presence 
of CK14 in the suprabasal stratums is not a parameter to predict malignancy. The CK in OLP do not follow the 
normal pattern of keratinized or non-keratinized mucosa.
Key words: Basal cell vacuolization, CK1, CK13, CK14, cytokeratin, lymphocytic exocytosis, oral lichen planus. 
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Introduction
Oral lichen planus (OLP) is a mucocutaneous inflam-
matory disease which affects 0.5 to 2.2% of population. 
It usually presents with a chronic course that includes 
frequent exacerbations (1). 
OLP is an example of autoimmunitary damage. The 
diagnosis must be based on the recognition of clinical 
alterations as well as on carrying out an interview with 
the objective of observing a possible cause–effect rela-
tionship to differentiate OLP from oral lichenoid reac-
tions (OLR) (2). In this report we only included patients 
with OLP. It has been reported that the clinical features 
alone may be sufficiently diagnostic, particularly when 
presenting in the classic reticular form. The evidence 
regarding the need and value of biopsy for histological 
confirmation of the diagnosis is not definitive. Studies 
have shown variability in both interobserver and in-
traobserver reliability in the clinicopathological assess-
ment of OLP (2).
Cytokeratins (CK) are a group of the intermediate fila-
ment proteins in the epithelium comprising a heterodim-
er of an acidic and a basic keratin (keratin pair) (3). In 
1982, Moll et al. found that there were 19 subclasses 
of CK and classified them according to their molecular 
weights. CK are place specific and may change when 
the growth rate rises or when the degree of differentia-
tion is altered pathologically (4). CKs are the main dif-
ferentiation markers of stratified epithelium. 
The pair CK5/CK14 is recognized as a specific marker 
of the basal layer of normal stratified epithelium (5) and 
it is the main component of hemidesmosomes (6). As 
they move away from the basal layer, keratinocytes fail 
to express these CKs and begin to express tissue-specif-
ic CKs. The major keratins of the interfollicular epider-
mis are CK10 and CK1. However cells of stratified non 
keratinized mucosa express CK4 and CK13 (7) (Fig. 1).
In oral mucosa, CK4 and CK13 are the predominant su-
prabasal CKs. However, small subpopulations of supra-
basal cells also express CK1 and CK10 (8). Hard palate 
and gingival mucosa express the same patterns as in the 
epidermis. The dorsal surface of the tongue and the lat-
eral border contain intermediate patterns between kerati-
nized and non keratinized epithelium (9). In contrast, the 
alveolar mucosa contains a large proportion of CK4 and 
CK13 and less CK5, CK6, CK14 and CK17 (10). 
CK1 synthesis starts earlier than CK10 which initiates 
its transcription when there are significant levels of CK1 
(11,12) (The presence of CK 1/10 in the epithelium in OLP 
in the basal and suprabasal layers has been reported) (13). 
In this article, we have explored the distribution of CK1, 
CK13 and CK14 in the oral mucosa lesions in patients 
with OLP and correlated their expression with clinical 
and histopathological patient data.   
Material and Methods
Subjects: Thirty female patients and three male patients 
with OLP, ranging in age from 40 to 85 years (average 
age, 61.6 years) were included. The biopsied lesions 
were located in three cases in the dorsal surface of the 
tongue, in three others in the palatal keratinized mu-
cosa and in the other 27 patients, in the nonkeratinized 
buccal mucosa (Table 1). The chief complaint was pain 
(93.8%). In fact, in the qualitative assessment, through 
an analogue pain scale from 0-10, patients had an aver-
age of 6.45 (SD ± 2.4). In 97.9% of the patients the le-
sions were multiple, predominantly erosive lesions (n = 
37), plaque lesions (n = 20) and erythema (n = 12). The 
main location was in the buccal mucosa (over 70%), fol-
lowed by the lips, tongue (dorsal and lateral region) and 
gums. There were lesions in the palate in 12.5% of the 
participants. The average evolution was 252.7 days with 
a range of 7-3285 days.
Fig. 1. Distribution of CK in normal skin and mucosa.
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Lesion site Drugs (n) CK1 CK13 CK14
Basal Suprabasal Basal Suprabasal Basal Suprabasal
1 KM 1 0 0 0-+ ++-+++ 0 0
2 KM 0 + ++ 0-+ +-+++ ++ ++-+++
3 KM 1 0 ++ 0 +-++ +++ +++
4 DST T, 3 + + + 0-++ + ++
5 DST 3 0 + ++ ++ +++ ++-+++
6 DST 5 0 +-++ 0 +-+++ +++ +++
7 NKM 1 0 0 0 0-+ ++ 0-+
8 NKM T, 0 0 ++ 0 +++ +++ ++-+++
9 NKM 2 - - 0 +-++ ++ 0
10 NKM 2 + 0-+ + 0-+ + +-++
11 NKM 2 0 0 + +-++ +++ ++
12 NKM 4 0 ++ 0 0-++ + +-++
13 NKM 2 0 +-+++ 0 +-++ ++ ++
14 NKM T,3 ++ +-++ 0 ++-+++ - -
15 NKM 4 0 +-++ + ++-+++ ++ +-++
16 NKM 0 0 0 - - ++ ++
17 NKM 6 0 +-++ 0 ++ + +-++
18 NKM 2 0 0 ++ 0-+ +++ +++
19 NKM 2 0 0 0 ++-+++ +++ +++
20 NKM 1 0 0 0-+ +-++ +++ +++
21 NKM 1 0 ++ 0 ++ +++ ++
22 NKM T, 5 0 ++-+++ 0 ++ +++ +++
23 NKM 3 0 0-+ - - +++ +++
24 NKM T, 2 0 0-+ 0 ++ +++ +++
25 NKM 3 0 0 0 +-++ +++ ++-+++
26 NKM 3 0 0-++ 0 +-+++ ++-+++ +-+++
27 NKM 3 0 0 0 + ++ ++
28 NKM 0 0 0 0 +-++ ++-+++ ++-+++
29 NKM 5 0 0 + +-++ ++ +
30 NKM 0 0 ++ + +++ +++ ++
31 NKM 2 + +-++ 0-+ +-++ ++ ++
32 NKM 3 0 +-++ 0 0-+++ ++ ++
33 NKM T, 0 - - 0-+ 0-+ ++ ++
Table 1. Expression of CK1, K13 and CK14 related to OLP lesions location, tobacco smoke and amount of drugs intake. KM: keratinized 
mucosa, DST: dorsal surface of tongue, NKM: nonkeratinized mucosa no queratinizada, T: tobacco, 0 No expression, + low expression, ++ 
moderate expression, +++ intense expression, - CK expression was not obtained due to technical problems.
Inclusion criteria: Biopses obtained from the oral mu-
cosa of patients with clinical manifestations of OLP 
were included in this study, according to WHO Clini-
cal diagnostic criteria: 1) Presence of bilateral, mostly 
symmetrical lesions; 2) Presence of network of slightly 
raised lines (reticular pattern); 3) Erosive, atrophic, bul-
lous, and plaque type lesions in presence of reticular 
lesions elsewhere in the oral mucosa).
The exclusion criteria were: 1) Patients younger than 16 
years old; 2) patients with OLR of graft-versus-host dis-
ease; 3) OLR seen in direct topographic relationship to 
amalgam; 4) OLR in temporal association with the tak-
ing of medications, based on the interview and observ-
ing possible cause–effect relationship.
Four patients with oral mucocele were enrolled into the 
study as controls. The present study was approved by 
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the Ethic Committee of the Lagomaggiore Hospital of 
Mendoza, Argentina. Written informed consent was 
obtained from each subject. Eighty seven percent of 
patients had other pathologies and 71% of them were 
on drugs treatment. The principal drugs administered 
were: antihypertensives (ACE inhibitors or angiotensin-
converting enzyme inhibitors, β-blockers and calcium 
channel blockers), non steroidal anti-inflammatory 
drugs (NSAIDs), antidepressants (benzodiacepins), 
thyroid hormones, calcium and alendronate. Twenty 
five percent of the patients were tobacco smokers. 
Biopsies: Samples were fixed in 10% formalin and em-
bedded in paraffin. Serial 5 µm-thick sections were 
mounted onto 3-aminopropyltrietoxysilane (Sigma, S. 
Louis, MO, USA)-coated slides. The histologic speci-
mens were stained with hematoxylin and eosin and the 
diagnosis was confirmed by optical microscopic exami-
nation. The presence of hyperkeratosis, parakeratosis, 
vacuolization of the basal layer, band-like infiltrate, ke-
ratinocytes necrosis, incontinentia pigmenti, dysplasia, 
lymphocytes exocytosis and sawtooth rete ridges were 
examined (14). These parameters were graduated: 0= 
absence, 1= low grade, 2= moderated and 3= severe. 
Immunohistochemistry: The immunohistochemical 
procedure was performed as reported previously (15). 
Mouse monoclonal antibodies against the CK1 (NCL-
CK1, clone 34βB4), CK13 (NCL-CK13, clone KS-1A3) 
and CK14 (NCL-L-LL002, cloneLL002) (Novocastra, 
Newcastle Upon Tyne, United Kingdom) were used. The 
antigen retrieval protocol was carried out in 0.01 M cit-
rate buffer, pH 6.0 at 100 °C for 25 min. Tissue sections 
were incubated with the primary antibodies overnight 
at 4°C in a humidity chamber at the following dilutions: 
CK1, 1:100; CK13, 1:200; CK14, 1:100. As secondary 
antibody we used anti-mouse IgG biotin conjugate and 
Avidin and Biotinylated horseradish peroxidase Com-
plex (Vectastain Universal Elite ABC, VECTOR, Burl-
inghame, CA, USA) were used.
Diaminobenzidine/hydrogen peroxide was used as a chro-
mogen substrate. Slides were counterstained with hema-
toxylin. The evaluation of the immunostaining was clasi-
fied as positive or negative in basal and suprabasal layers.
Statistical Analysis: Fisher’s exact test was used to de-
termine whether the expression of the CK studied cor-
related significantly with the intake of different drugs 
or smoke. Mann Whitney test and t test with Welch cor-
rection were applied to compare means of the grades 
of histological changes detected related to the expres-
sion of CKs. Statistical analysis was performed using 
the Prism computer program (Graph Pad Software, San 
Diego, CA); p< 0.05 was considered significant.
Results
In the control group the usual pattern of expression of CK 
present in non keratinized normal mucosa was observed 
(Fig. 2). Thirty one biopsies were immunostained with 
CK1; 5 of them were positive in the basal layer (16%) 
and 20 were positive in the suprabasal layers (64%) (Fig. 
2). In six of these patients, the biopsies were taken from 
keratinized mucosa (KM); three from hard palate muco-
sa and three from the dorsal surface of the tongue (DST) 
(Table 1). In five of them, CK1 was positive in the supra-
basal layer, and in two of those, CK1 was also positive 
in the basal layer. The expression of CK1 and CK14 was 
negative in one patient with biopsy from KM and posi-
tive for CK13. This suggests a change in the pattern of 
keratinization. In our patients with OLP, the expression 
of CK1 in NKM was positive in 15 samples and negative 
in 10 samples. Tobacco smoke was present in 4 of these 
patients. CK1 expression was positive in NKM of all the 
smokers in the suprabasal layers, and also in the basal 
layer in two of those smokers. In the group of NKM from 
non smokers patients (n=21) CK1 was positive in the su-
prabasal layer in 10 patients. No significant difference 
was observed in the expression of CK1 in patients with 
or without drug treatment and there was no association 
with the amount of drugs intake or smoking. When the 
tisular afectation was compared with the expression of 
CK1, no correlation was found. 
Thirty one samples were immunostained with CK13, 
resulting all of them positive in the suprabasal layers 
and 13 positive in the basal layer (42%) (Fig. 2). In KM, 
CK13 was expressed in 4 out of 6 samples in the basal 
layer. In NKM, in the basal layer, CK13 was negative in 
16 samples and positive in 9. CK13 was positive in the 
24 biopsies of NKM in the suprabasal layers.
When CK13 was expressed in the basal cells, statisti-
cal analysis showed a significantly higher degree of 
vacuolization of this layer (p=0.023) and of exocytosis 
(p=0.0025) (Table 2).
CK14 was expressed in the basal layer of 31 samples 
(97%, 31/32) and in the suprabasal layer of 30 samples 
(94%, 30/32) (Fig. 2). The expression of CK14 in the su-
prabasal layers was more intense than in the basal layer 
in five samples.
Discussion
We observed CK1 expression in 64% of our specimens 
in the suprabasal layer and in 16% in the basal layer. 
Our research differs from the ones made by other au-
thors, since the presence of CK1 does not have a direct 
connection with the presence of orthokeratosis. In 1999, 
Chaiyarit et al., reported that the expression of CK1/10 
in the epithelial basal and suprabasal layers was signifi-
cantly higher in OLP than in the fibroids and that HSP60 
presence in the basal layer was significantly superior in 
the samples of OLP. These authors suggested that many 
cytokines hidden by the T lymphocytes present during 
the infiltration, might influence the presence of differ-
ent CK genes in the adjacent keratinocytes (13). 
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Fig. 2. Expression of CK1, CK13 and CK14 in NKM of controls and in NKM of OLP. 
HK/PK VAC BD INF K NEC INC  PIG DYSPL EXOC ST R R
Suprabasal 
CK1
p=0.25 p=0.78 p=0.65 p=0.13 no comparable p=0.71 p=0.88 p=0.05
Basal
CK13
p=0.42 p=0.023 p=0.30 p=0.27 p=0.76 p=0.16 p=0.0025 p=0.11
Table 2. CKs association with histopathological changes. CK1 expressed in 64% of the samples in the basal layer and CK 13 in 42% of the 
specimen in suprabasal layers. Expression of basal CK1 (16%), suprabasal CK13 (100%), basal CK14 (97%) and suprabasal CK14 (94%) resulted 
not comparable with histopathological changes. Abbreviations: HK/PK: hyperkeratosis/parakeratosis, VAC: vacuolization of the basal layer, 
BD INF: band-like infiltrate, K NEC: keratinocytes necrosis, INC PIG: incontinentia pigmenti, DYSPL: dysplasia, EXOC: lymphocytes 
exocytosis and ST R R: sawtooth rete ridges. 
Later Bloor et al. showed that CK1 and CK10 synthe-
sis was higher in the orthokeratinized epithelium and 
that the proximity of lymphocytes and their cytokines 
reduced the presence of the specific CK and their dif-
ferentiation (8). Van der Velden et al. found weak ex-
pression of CK10 in OLP and in oral hiperplasias (16) 
Jaques et al obtained negative CK10 expression in 16/17 
samples in the suprabasal layer in OLP and no expres-
sion in the basal layer (6). In 2010, Donetti et al proved 
that the presence of desmoglein 3 (dsg3) and CK10 is 
altered in the keratinized oral mucosa of smoking pa-
tients (17). Chaiyarit et al also claimed a hypothesis for 
the pathogenesis of OLP: in a genetically predisposed 
individual, an hapten, which is a conventional antigen 
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or a super antigen originated in the oral microbial flora, 
can lead to an immune reaction, interceded by a cell 
with a subepithelial infiltration of lymphocytes.
Later, other authors presented similar unifying etio-
pathogenic models of OLP. At the first stage basal ke-
ratinocytes are ‘‘activated’’ by different antigens, which 
promotes the expression of heat-shock/stress-response 
proteins in a variant fashion. These proteins may act 
as a self-antigen induced on basaloid keratinocytes 
via innate immune response activation. Cytotoxic and 
pro-apoptotic mediators/stimuli expressed by fully ac-
tivated cytotoxic CD8 T cells could then mediate the 
basal cell layer apoptosis and necrosis that is typical of 
lichen planus. It is also possible that the first antigen 
and the second antigen could represent the same mo-
lecule (18). An example might be a chemical hapten 
(19). Some examples of exogenous stimulus capable of 
starting an autoperpetuating cascade may be certain 
drugs, dental materials and infections. The generation 
of cytokines by these cells can positively regulate the 
presence of HSP60 in the basal adjacent keratinocytes. 
The next step depends on the individual’s predisposal to 
a reaction to HSP60. If he is not predisposed, the first 
immune reaction will result in an unspecified mucositis. 
However, if the individual is predisposed to react to the 
HSP60 due to the presence of HLA antigens like the 
HLA-Bw57 or the HLA-DR2 in his body, then a second 
immune reaction will continue with the TL develop-
ment which target the basal keratinocytes, resulting in 
their destruction (13).
Our findings are greatly supported by this theory, be-
cause normally CK1 and CK13 are not expressed in ba-
sal layers of the epithelium, neither CK1 in NKM. 
In our study, CK13 was observed in 42% of the sam-
ples in the basal layer. We found a direct association 
with the degree of basal layer vacuolization, and the 
degree of lymphocytes exocytosis with the expression 
of CK13 in the basal layer. Bloor et al. detected CK4 
and CK13 homogeneously spread in the suprabasal 
compartment of the parakeratotic epithelium in OLP 
(8). The finding of CK13 in the basal layer, suggests a 
jump in the presence/expression of CK, which should 
be in superior stratums, and is related to the aggres-
sion of the infiltrate to the epithelium, reliable through 
the basal stratum vacuolization and increased lym-
phocytic exocitosis.
We observed CK14 expression in 97% of the samples 
in the basal and in 94% in the suprabasal stratums. The 
presence of CK14 on the suprabasal stratums may be 
an indication of a flaw in the cytological differentia-
tion. This may be showing a sort of immaturity in those 
levels. However, according to our study, this parameter 
should not be studied since it is expressed in nearly all 
the OLP, and that is known that not all the OLP suffer 
from malignant transformation.
It has been reported that patients with OLR have an 
increased risk of oral cancer, particularly important in 
patients who have atrophic, erosive or ulcerative lesions 
(20). As OLR have also clinical criteria, we excluded 
them from our sample. These include lichenoid contact 
lesions, lichenoid drug reactions and lichenoid lesions 
of graft-versus-host disease. In spite of this, in some 
cases there is a spectrum of OLR that may confuse the 
differential diagnosis (2). OLP is a chronic disease, in 
most of our patients it evolved during years. Many of 
them have multiple amalgam restorations, but at the 
time of inclusion in this work, they fulfilled the diag-
nosis criteria for OLP. Besides drug intake was present 
in most patients, but it had no chronological correlation 
with the disease. 
Our results are concordant with Jaques et al. who found 
CK14 in basal and suprabasal layers in the 23 samples 
analyzed (6). On the other hand, we do not agree with 
Brunotto et al, who claimed that the positive immunos-
taining of CK14 in the superficial epithelial stratums of 
OLP should be a sufficient malignant sign to begin new 
exams (5). Our discordance is based on the fact that ma-
lignancy of around 5% of OLP has been reported in the 
literature and that the expression of CK14 is found in 
97% of the suprabasal layers. Besides, only one of our 
patients developed an oral squamous carcinoma in five 
years follow-up. This patient presented symmetrical le-
sions of erosive OLP and he was also tobacco smoker. 
His lesions had clinical WHO criteria for OLP, and he 
also had typical lichen affection in nails (nail pterygium). 
Therefore patients diagnosed with OLP must be followed 
up, as well as those with OLR, especially in erosive, 
atrophic, bullous and keratotic forms, for early diagnosis 
of malignant transformation if that occurs (21).
Conclusions
CK1 was present in 64% of the specimens in the su-
prabasal layer and in 16% in the basal layer, in patients 
with OLP.
CK13 was observed in 42% of the samples in the basal 
layer, this has not been described previously in other 
studies. The presence of CK13 in the basal layer was as-
sociated with a higher degree of vacuolization of the ba-
sal layer and with the presence of important exocitosis.
CK14 was positive in 97% of the samples in the basal 
layer and in 94% in the suprabasal stratums.
The three CK were altered in the OLP. In conclusion, 
the CKs in the OLP do not follow the normal patterns of 
keratinization in keratinized or non-keratinized mucous 
epitheliums.
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